# US 2021/0267523 A1 · Neural Interface System

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0267523 A1
- Document ID: US20210267523A1
- Status: Published application
- Kind: A1
- Application number: 17/051,599
- Filed: 2019-04-30
- Published: 2021-09-02
- Earliest claimed: 2018-05-01
- Assignees: Wyss Center for Bio and Neuro Engineering
- Applicants: Wyss Center for Bio and Neuro Engineering
- Inventors: John P. Donoghue; Georgios Kouvas; Aleksander Sobolewski; Jonas Zimmermann; Ioannis Vlachos; Maxime Baud; J. Christopher Flaherty
- Web page: https://patentgrep.com/patent/US20210267523A1

## CPC

- A61B 5/293: Invasive
- A61B 5/002: {Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence)}
- A61B 5/0031: {Implanted circuitry}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/0261: {using optical means, e.g. infrared light}
- A61B 5/37: Intracranial electroencephalography [IC-EEG], e.g. electrocorticography [ECoG]
- A61B 5/386: Accessories or supplementary instruments therefor
- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61B 5/7217: {of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker}
- A61N 1/0504: {Subcutaneous electrodes}
- A61N 1/0529: {Electrodes for brain stimulation}
- A61N 1/36135: {using physiological parameters}
- A61B 5/02055: {Simultaneously evaluating both cardiovascular condition and temperature}
- A61B 5/4094: {Diagnosing or monitoring seizure diseases, e.g. epilepsy}
- A61B 5/4812: {Detecting sleep stages or cycles}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/6868: {Brain}
- A61B 2560/063: Devices specially adapted for delivering implantable medical measuring apparatus
- A61B 2562/182: Electrical shielding, e.g. using a Faraday cage
- A61N 1/36064: {Epilepsy}
- A61N 1/36067: {Movement disorders, e.g. tremor or Parkinson disease (stimulating motor muscle A61N1/36003)}
- A61N 1/36071: {Pain}
- A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease}
- A61N 1/361: {Phantom sensations, e.g. tinnitus}
- A61N 1/36103: {Neuro-rehabilitation; Repair or reorganisation of neural tissue, e.g. after stroke}
- A61N 1/37211: {Means for communicating with stimulators}
- A61N 1/37514: {Brain implants}
- G06F 3/015: {Input arrangements based on nervous system activity detection, e.g. brain waves [EEG] detection, electromyograms [EMG] detection, electrodermal response detection}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)

## Abstract

Provided herein are neural interface systems for a patient, the systems comprising an implantable sensor device and an external processing device. The implantable sensor device comprises: an implantable lead assembly for implantation above the skull and below the skin of the patient, and for recording physiologic parameter information of the patient; and an implantable transmitter for receiving the physiologic parameter information from the implantable lead assembly and for transmitting patient data that is based on the physiologic parameter information. The external processing device receives the patient data from the implantable transmitter. Methods of provided a neural interface are also described.

## Claims

### Claim 1

A neural interface system for a patient comprising:
an implantable sensor device comprising;
an implantable lead assembly for implantation above the skull and below the skin of the patient, and for recording physiologic parameter information of the patient, and
an implantable transmitter for receiving the physiologic parameter information from the implantable lead assembly and for transmitting patient data that is based on the physiologic parameter information; and
an external processing device for receiving the patient data from the implantable transmitter,
wherein the implantable lead assembly comprises multiple electrodes, the multiple electrodes comprising at least six tubular electrodes, the implantable lead assembly comprising multiple leads, each lead comprising at least one electrode, the implantable lead assembly being configured to be implanted in a geometry that defines a convex hull that covers at least 50% of the convexity of the cerebral hemispheres of the patient.

### Claim 2 (depends on 1)

The system according to claim 1, wherein the implantable lead assembly is configured to obtain broad coverage of the patient's brain by comprising multiple leads, each lead comprising at least one electrode, the multiple leads being configured to be implanted in a star shaped geometry and each of the multiple leads being configured to be tunneled under the skin.

### Claim 3 (depends on 1)

The system according to claim 1, wherein the electrodes comprise two or more facet electrodes that span less than 180 degrees of a circumferential segment, the two or more facet electrodes being individually selectable and the two or more facet electrodes comprising a first facet electrode for recording the physiologic parameters and a second facet electrode used for noise suppression, the second facet electrode being configured to be oriented away from the skull of the patient after an implantation.

### Claim 4 (depends on 1)

The system according to claim 1, wherein the electrodes comprise at least one concentric ring electrode surrounding a central electrode, the implantable lead assembly comprising at least one electrode comprising a shielded portion.

### Claim 5 (depends on 1)

The system according to claim 1, wherein the multiple leads comprise at least six leads, each lead comprising between three and ten electrodes, the multiple leads being folded into a single tube geometry.

### Claim 6 (depends on 1)

The system according to claim 1, wherein the implantable lead assembly comprises a central conduit operably attached to the implantable transmitter and to each of the multiple leads, the multiple leads being arranged in a staggered geometry, each lead extending from the central conduit.

### Claim 7 (depends on 1)

The system according to claim 1, wherein at least a portion of the implantable sensor device is biodegradable, said biodegradable portion comprising at least a portion of a component selected from the group consisting of: a lead or other conduit of the implantable lead assembly; an electrode of the implantable lead; a shaft of the implantable lead; a stimulation element; and combinations thereof.

### Claim 8 (depends on 1)

The system according to claim 1, wherein each lead comprises one or more axial reinforcing elements, each axial reinforcing element comprising a reinforcing filament, said reinforcing filament comprising materials and a construction configured to withstand forces incurred during engagement with one or more tunneling tools and/or during engagement with one or more removal tools.

### Claim 9 (depends on 1)

The system according to claim 1, wherein the implantable lead assembly comprises at least one sensor, the system further comprising a visualizable marker positioned relative to the at least one sensor, the visualizable marker comprising an infrared diode or a marker selected from the group consisting of: radiopaque marker; ultrasound marker; magnetic marker; and combinations thereof.

### Claim 10 (depends on 1)

The system according to claim 1, wherein the system further comprises at least one intracranial sensor operably connected to the implantable transmitter, the at least one intracranial sensor comprising epidural, subdural, and/or depth electrodes.

### Claim 11 (depends on 1)

The system according to claim 1, wherein a lead of the implantable lead assembly comprises a substrate with a relatively flat geometry, a width of up to 3.5 mm and a length of approximately 10 cm, said lead further comprising multiple electrode-based sensors with a length of approximately 5 mm, each sensor being configured to be positioned on the substrate of the lead with an approximately 25 mm center-to-center separation distance from a neighboring sensor.

### Claim 12 (depends on 1)

The system according to claim 1, wherein said system is configured to stimulate brain tissue to achieve always available neuromodulation.

### Claim 13 (depends on 1)

The system according to claim 1, wherein the system includes one or more tools, said one or more tools comprising an introducer tool configured to tunnel one or more leads of the lead assembly under a skin of the patient.

### Claim 14 (depends on 1)

The system according to claim 1, wherein it is configured to provide self-administered, always available, neurofeedback.

### Claim 15 (depends on 1)

The system according to claim 1, wherein one or more sensors of the implantable lead assembly comprises one or more functional near infrared spectroscopy, fNIRS, sensors and/or at least one foramen ovale electrode.
